Download PDF of Recommendations The Washington Post (9/7, McGinley) highlights a report released by a “blue-ribbon panel” of “top cancer researchers and patient advocates” as part of the White House’s cancer moonshot. The report...

Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention.  In one of the pieces I mentioned...

Science, health care and technology conglomerate Danaher Corp. DHR 0.28 % said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. CPHD -0.20 % for $53.00 a share, in its first major acquisition since spinning off a...

A book review on our recent book "Digital Pathology: Historical Perspectives, Current Concepts & Future Applications" was written by Dr. Paul J van Diest, Professor of Pathology and Chairman, Department of Pathology, UMC Utrecht, The...

Many of you have already been contacted about this in the past few months. Perhaps repeatedly. Through this site, emails, in-person and/or by phone.  And many of you have generously supported these rides and organization. Time is close for the...

Potential new technology here that may limit number of breast biopsies previously deemed "unnecessary" using artificial intelligence to aid screening with mammography with tumor protein expression. Perhaps as many as 20% of breast biopsies...